Ron Suskind is a Pulitzer Prize-winning journalist and best-selling author, lecturer at Harvard Law School, and founder and chief executive officer of The Affinity Project/Sidekicks, a developer of augmentative technologies for ‘at need’ populations, starting with autism.
Ron Suskind
Founder
The Affinity Project/Sidekicks
From this contributor
Animated sidekick connects parents to children with autism
In a new type of therapy for autism, parents talk or type into their phone or computer, and their words emerge in the voice of an animated character.
Animated sidekick connects parents to children with autism
By
Ron Suskind
21 February 2017 | 9 min read
Explore more from The Transmitter
Personalized medicine; astroglia organoids; fast track for fragile X drug
Here is a roundup of autism-related news and research spotted around the web for the week of 20 January.
Personalized medicine; astroglia organoids; fast track for fragile X drug
Here is a roundup of autism-related news and research spotted around the web for the week of 20 January.
By
Jill Adams
21 January 2025 | 2 min read
Neuroscientists need to do better at explaining basic mental health research
The knowledge gap between scientists, health-care professionals, policymakers and people with mental health conditions is growing, slowing the translation of basic science to new treatments. Like lawyers learning to present a case to the court, scientists should learn to educate nonscientists about their findings.
Neuroscientists need to do better at explaining basic mental health research
The knowledge gap between scientists, health-care professionals, policymakers and people with mental health conditions is growing, slowing the translation of basic science to new treatments. Like lawyers learning to present a case to the court, scientists should learn to educate nonscientists about their findings.
By
Omar Abubaker, Karla Kaun, Eric J. Nestler
21 January 2025 | 7 min read
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
By
Carina Heller
20 January 2025 | 7 min read